CHAPPIE, Thomas Allen,HAYWARD, Matthew Merrill,HELAL, Christopher John,LACHAPELLE, Erik Alphie,PATEL, Nandini Chaturbhai,SCIABOLA, Simone,VERHOEST, Patrick Robert,YOUNG, Joseph Michael
申请号：
TN2017000031
公开号：
TN2017000031A1
申请日:
2015.07.23
申请国别(地区):
TN
年份:
2018
代理人:
摘要：
The present invention is directed to compounds of Formula 1: or a pharmaceutically acceptable sait thereof, wherein the substituents R<；sup>；1<；/sup>；, R<；sup>；3<；/sup>；, R<；sup>；6<；/sup>；, R<；sup>；7<；/sup>； , and b are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.
